The basis for selective death of specific neuronal populations in neurodegenerative diseases remains unclear. Parkinson's disease (PD) is a synucleinopathy characterized by a preferential loss of dopaminergic neurons in the substantia nigra (SN), whereas neurons of the ventral tegmental area (VTA) are spared. Using intracellular patch electrochemistry to directly measure cytosolic dopamine (DA cyt ) in cultured midbrain neurons, we confirm that elevated DA cyt and its metabolites are neurotoxic and that genetic and pharmacological interventions that decrease DA cyt provide neuroprotection. L-DOPA increased DA cyt in SN neurons to levels 2-to 3-fold higher than in VTA neurons, a response dependent on dihydropyridine-sensitive Ca 2+ channels, resulting in greater susceptibility of SN neurons to L-DOPAinduced neurotoxicity. DA cyt was not altered by a-synuclein deletion, although dopaminergic neurons lacking a-synuclein were resistant to L-DOPAinduced cell death. Thus, an interaction between Ca 2+ , DA cyt , and a-synuclein may underlie the susceptibility of SN neurons in PD, suggesting multiple therapeutic targets.
SUMMARY
The basis for selective death of specific neuronal populations in neurodegenerative diseases remains unclear. Parkinson's disease (PD) is a synucleinopathy characterized by a preferential loss of dopaminergic neurons in the substantia nigra (SN), whereas neurons of the ventral tegmental area (VTA) are spared. Using intracellular patch electrochemistry to directly measure cytosolic dopamine (DA cyt ) in cultured midbrain neurons, we confirm that elevated DA cyt and its metabolites are neurotoxic and that genetic and pharmacological interventions that decrease DA cyt provide neuroprotection. L-DOPA increased DA cyt in SN neurons to levels 2-to 3-fold higher than in VTA neurons, a response dependent on dihydropyridine-sensitive Ca 2+ channels, resulting in greater susceptibility of SN neurons to L-DOPAinduced neurotoxicity. DA cyt was not altered by a-synuclein deletion, although dopaminergic neurons lacking a-synuclein were resistant to L-DOPAinduced cell death. Thus, an interaction between Ca 2+ , DA cyt , and a-synuclein may underlie the susceptibility of SN neurons in PD, suggesting multiple therapeutic targets.
INTRODUCTION
Parkinson's disease (PD) is characterized by aggregation of alpha-synuclein (a-syn) into Lewy bodies and Lewy neurites, and a progressive loss of specific neuronal populations. In particular, ventral midbrain (VM) dopamine (DA) neurons of the substantia nigra (SN) preferentially degenerate in PD, while neighboring ventral tegmental area (VTA) DA neurons are relatively spared (Dauer and Przedborski, 2003) . A role of a-syn in PD pathogenesis is demonstrated by cases of familial PD that result from mutations or overexpression of a-syn, as well as by the observation that SN neurons in mice with a-syn deletion are protected against the parkinsonian neurotoxins MPTP and 6-OHDA (Alvarez-Fischer et al., 2008; Dauer et al., 2002) . Several hypotheses may explain a-syn-mediated cytotoxicity, including the formation of toxic aggregates that disrupt membrane (Conway et al., 2001 ), a blockade of lysosomal protein degradation (Martinez-Vicente et al., 2008) , and mitochondrial dysfunction (Ved et al., 2005) . It has also been recently suggested that high Ca 2+ levels due to Ca v 1.3 channel-dependent pacemaking activity (Nedergaard et al., 1993 ) may contribute to SN susceptibility, as VTA neurons use Na + channels for pacemaking (Chan et al., 2007) . Accordingly, Ca v 1.3 antagonists block SN cell death in MPTP and other neurotoxin models (Chan et al., 2007) . The reason for the preferential death of SN DA neurons is, however, unclear, as both a-syn and Ca v 1.3 channels are expressed throughout the CNS in neurons that are not lost in PD (Clayton and George, 1998; Rajadhyaksha et al., 2004; Striessnig et al., 2006) .
A long-standing hypothesis of neurodegeneration in PD postulates that the buildup of cytosolic DA (DA cyt ) with associated oxyradical stress and its possible interaction with a-syn and other PD-related proteins underlie neurotoxicity (Caudle et al., 2008; Chen et al., 2008; Edwards, 1993; Pardo et al., 1995; . A role for DA cyt in the selectivity of cell death in PD, however, has never been directly studied due to a lack of means to measure DA cyt . Here we use a new electrochemical approach to measure DA cyt in neurons following various pharmacological and genetic interventions. We report that ''multiple hits'' consisting of high cytoplasmic Ca 2+ , elevated DA cyt , and a-syn expression are required to evoke selective death of dopaminergic neurons from SN and show that interference with any of these three factors rescues the neurons.
RESULTS
We previously introduced intracellular patch electrochemistry (IPE) to study the regulation of cytosolic catecholamine homeostasis in cultured primary murine adrenal chromaffin cells (Mosharov et al., 2003) and the PC12 cell line (Mosharov et al., 2006) . To extend IPE measurements to DA neurons, we employed VM cultures from mice that express green fluorescent protein under the control of the tyrosine hydroxylase (TH) promoter (TH-GFP; see Figure S1 available online) (Sawamoto et al., 2001) . Immunolabeling of fixed 2-week-old cultures of VM neurons for TH showed that approximately 97% of GFP + cells were TH + (185 of 191 cells).
Dependence of DA cyt on Extracellular L-DOPA IPE measurements in cyclic voltammetric (CV) mode that detects DA preferentially over other intracellular metabolites (including L-3,4-dihydroxyphenylalanine [L-DOPA] and dihydroxyphenylacetic acid [DOPAC] ) revealed that DA cyt in untreated GFP + neurons was below the detection limits of the technique (<0.1 mM). This was similar to DA cyt levels in PC12 cells (Mosharov et al., 2006) , but differed from the 10-20 mM cytosolic catecholamine concentrations found in untreated chromaffin cells (Mosharov et al., 2003) . We previously demonstrated that 1 hr pretreatment with (C) HPLC-EC measurements of the total intracellular DA and DOPAC in rat VM (n = 9 dishes) and cortical (n = 3) neuronal cultures exposed to 100 or 500 mM L-DOPA for 1 hr; N.D., not detected. *p < 0.05 versus untreated cultures.
(D) HPLC measurements of intracellular L-DOPA contents in rat VM cultures pretreated with the AADC inhibitor benserazide (2 mM; 1 hr) and then treated with 50, 100, or 500 mM L-DOPA for 1 hr (n = 3-8 dishes). Solid line indicates the fit of the data points using the equation
(E) Dependence of the rate of L-DOPA auto-oxidation on the initial L-DOPA concentration determined by HPLC-EC in a cell-free system. The half-life was calculated from the incline (k) of the linear fit of the data points as t 1/2 = Ln(2)/k. 100 mM L-DOPA produces a 2-to 3-fold increase of cytosolic catecholamine concentration in chromaffin cells (Mosharov et al., 2003) . The same dose of L-DOPA increased DA cyt in GFP + neurons to 17.4 ± 1.7 mM (mean ± SEM; n = 74 cells). To determine the kinetics of DA cyt changes after L-DOPA treatment, we performed IPE at 1, 8, 15, and 24 hr after L-DOPA addition to the media. After 1 hr of 100 mM L-DOPA exposure, DA in the cytosol reached a steady-state level that was maintained for $8 hr, followed by a decline to control levels over the succeeding 24 hr of drug treatment ( Figure 1A ). Interestingly, 500 mM L-DOPA increased DA cyt to the same maximum level, but the elevated steady state was maintained longer, and 24 hr after L-DOPA treatment, DA cyt was still higher than in untreated cells. To study the dependence of DA cyt on extracellular L-DOPA, neuronal cultures were treated with a range of L-DOPA concentrations for 1 hr at 37 C, followed by IPE measurements in the presence of the same L-DOPA concentrations in the bath and in the pipette solutions within the following 30 min at room temperature. The drug response curve was hyperbolic ( Figure 1B ) with an apparent K 0.5 of $10 mM L-DOPA.
As the steady-state DA concentration in neuronal cytosol is regulated by multiple enzymes and transporters, we attempted to determine which metabolic step limited DA cyt accumulation in L-DOPA-treated cells. High-performance liquid chromatography with electrochemical detection (HPLC-EC) measurements of the total intracellular DA (the majority of which represents vesicular DA; Chien et al., 1990; Mosharov et al., 2003) and DOPAC contents showed that these metabolites were elevated to the same degree in neurons exposed to 100 and 500 mM L-DOPA ( Figure 1C ), indicating that there was no difference in the rates of DA oxidation by monoamine oxidase A (MAO) and vesicular uptake by vesicular monoamine transporter 2 (VMAT2). To establish whether L-DOPA transport into the cell or its conversion to DA by aromatic L-amino acid decarboxylase (AADC) limited the L-DOPA metabolic consumption, we measured total intracellular L-DOPA levels in VM cultures after 1 hr treatment with 100 and 500 mM L-DOPA concentrations in the presence of the AADC inhibitor benserazide to block DA synthesis ( Figure 1D ). The initial rate of L-DOPA accumulation in the cells was not saturated under these conditions, consistent with previously published data (Sampaio-Maia et al., 2001 ) on the kinetics of L-DOPA uptake by cell lines derived from astrocytes and neurons (K m = 50-100 mM). Overall, these data suggest that the activity of AADC limits the steady-state DA cyt concentration following L-DOPA treatment.
The data in Figure 1C also provide information about the rate of L-DOPA turnover by the cells. The combined rate of DA and DOPAC synthesis during 1 hr of L-DOPA exposure was $40 fmol/mg of total protein. As each culture dish typically contained 50 À100 mg of total protein, the rate of L-DOPA consumption during 10 hr of incubation was 20-40 pmol per culture. This rate, however, is too low to account for the decline in the DA cyt observed after 10 hr of cell incubation with L-DOPA ( Figure 1A ), as the total amount of available L-DOPA was >3 orders of magnitude higher (200 nmol in 2 ml of 100 mM solution). We therefore examined the availability of extracellular L-DOPA, which is known to auto-oxidize to DOPA-semiquinone and DOPA-quinone derivatives . HPLC-EC measurements of L-DOPA concentration in cell-free media showed that the drug disappeared with first-order kinetics and a half-life of 4.7 hr ( Figure 1E ). This suggests that after 100 or 500 mM L-DOPA initial doses, its concentration in the media would reach the K 0.5 levels in 16 or 26 hr, respectively ( Figure 1F ), which is in close agreement with the kinetics of DA cyt changes, as a significant decrease in its initial steady state was observed at approximately these time points ( Figure 1A ). Together, these data allow us to predict the time dependence of DA cyt changes based on the concentration of L-DOPA added to the media and the initial increase in DA cyt determined by IPE (see Discussion).
L-DOPA-Induced Neurotoxicity
We next investigated whether exposure to various L-DOPA concentrations, and thereby different durations of sustained elevated DA cyt , correlated with neurotoxicity. We identified an exponential dependence of neurotoxicity on the extracellular L-DOPA concentration (Figure 2A ), whereas the time dependence for cell survival in cultures treated with 250 mM L-DOPA demonstrated that the number of TH + neurons declined linearly after drug exposure, reaching $50% of the control levels after 4 days, with no subsequent neuronal loss ( Figure 2B ). As L-DOPA at this concentration is cleared within $22 hr, the data indicate a lag between the end of L-DOPA/DA-mediated stress and the completed course of the catechol-induced toxicity. For further experiments we exposed cultures to 250 mM L-DOPA, which consistently produced $50% loss of VM dopaminergic neurons 4 days following drug addition. Extracellular DA released by neuronal activity did not seem to play a significant role in the L-DOPA-induced cell death, as neuronal viability was not affected by the Na + channel blocker tetrodotoxin (TTX; 1 mM), which inhibits stimulation-dependent transmitter release (data not shown). To further determine which pool of DA was responsible for the observed cell damage, we employed postnatal cultures of cortical and striatal neurons, which do not express TH, DAT, or VMAT. Following L-DOPA treatment of cortical neurons, we detected small amounts of DA measured by HPLC-EC ( Figure 1C ) and a substantial elevation of DA cyt measured by IPE ( Figure 2C ). This was accompanied by >60% loss of cells immunoreactive to microtubule-associated protein 2 (MAP2), which was used as a neuronal marker ( Figure 2D ). L-DOPA neurotoxicity was NSD-1015 sensitive, Neuron Dopamine, Calcium, a-Synuclein, and Neurotoxicity confirming AADC-mediated DA synthesis in cortical neurons (data not shown). In contrast, almost no DA cyt was detected in L-DOPA-treated striatal neurons, and they were spared following L-DOPA challenge ( Figures 2C and 2D ). Together, our data suggest DA cyt as the primary source of the L-DOPA-induced neurotoxicity.
Pharmacological Manipulation of DA cyt and Neurotoxicity AADC, MAO, and VMAT Inhibitors To study the contribution of individual metabolic pathways in the maintenance of the DA cyt steady state and to determine whether changes in DA level correlate with neurotoxicity, we performed metabolite measurements and toxicity studies on L-DOPAtreated neurons that were preincubated with specific inhibitors of AADC, MAO, and VMAT. Inhibition of the DA-synthesizing enzyme AADC with NSD-1015 (Figures 3A and 3B) or benserazide (not shown) blocked L-DOPA-induced elevation of wholecell intracellular DA and DOPAC. Benserazide also inhibited the buildup of DA cyt following L-DOPA treatment ( Figure 3C ), consistent with the idea that the IPE oxidation signal comes from DA synthesized by AADC in the cytosol (note that NSD-1015 alters IPE sensitivity for DA, and therefore was not examined; see Experimental Procedures). Moreover, the blockade of L-DOPA decarboxylation completely prevented drug-induced cell death ( Figure 3D ), indicating that an L-DOPA metabolite, but not L-DOPA itself, was responsible for the toxicity. The contribution of DA catabolism was investigated by treating cells with pargyline, an inhibitor of MAO that almost completely abolished DOPAC synthesis ( Figure 3B ). Pargyline also produced a several-fold increase in both the total amount of intracellular DA ( Figure 3A ) and DA cyt ( Figure 3C ) in L-DOPAtreated neurons, which further correlated with a significantly greater neuronal loss ( Figure 3D ).
The blockade of VMAT-mediated DA uptake into the vesicles depletes vesicular catecholamine storage, as observed by a reduction in the exocytotic quantal size (Colliver et al., 2000) . Consistently, pretreatment of VM neurons with reserpine decreased the amount of total intracellular DA synthesized from L-DOPA by $2-fold both with and without pargyline ( Figure 3A ). We observed, however, no effect of reserpine, or another VMAT inhibitor, tetrabenazine (10 mM; data not shown), on either DA cyt or the number of surviving dopaminergic neurons ( Figures 3C and 3D ).
Methamphetamine and Cocaine
The discrepancy between the reduction of the total DA in reserpine-treated neurons and the lack of the effect of VMAT inhibition on DA cyt might be explained by the distribution of synaptic vesicles between neuronal cell bodies and the neurites. If the majority of vesicles filled with DA are located in synaptic terminals far from the cell bodies, any transmitter redistributed from them would be invisible to IPE (see Experimental Procedures).
To examine the effects of other DA-releasing drugs on somatic DA concentration, we exposed L-DOPA-treated neurons to methamphetamine (METH), which disrupts the vesicular proton gradient and redistributes DA from synaptic vesicles to the cytosol . In contrast to the increased cytosolic catecholamine levels observed in chromaffin cells acutely treated with METH (Mosharov et al., 2003) , neurons exposed to 50 mM METH showed decreased DA cyt ( Figure 3E ); 5 mM METH produced the same decrease of DA cyt (38% of untreated cells; p < 0.005 by t test). METH-mediated reduction of DA cyt was blocked by the DA uptake transporter (DAT) inhibitor cocaine, suggesting that the effect was due to reverse transport through DAT . METH-mediated decrease of DA cyt and its blockade by cocaine were also observed in L-DOPA-treated cells in the presence of pargyline (data not shown). Note that DA cyt in L-DOPAtreated neurons was unaffected by DAT inhibitors cocaine ( Figure 3E ) or nomifensine (5 mM; data not shown), supporting the idea that reverse transport is not induced by the elevated DA cyt alone, but requires additional METH-mediated effects on DAT (Kahlig et al., 2005) . Neuron Dopamine, Calcium, a-Synuclein, and Neurotoxicity Consistent with the IPE results, METH protected neuronal cell bodies from L-DOPA toxicity ( Figure 3F ), despite the considerable neurite loss that occurs in METH-treated cultured DA neurons (Cubells et al., 1994; Larsen et al., 2002) . When applied for 4 days without L-DOPA, neither METH or cocaine nor the combination of the two drugs had a significant effect on the number of surviving neurons (data not shown).
Genetic Manipulation of DA cyt and Neurotoxicity VMAT2 Overexpression We previously developed a recombinant adenovirus that overexpresses VMAT2 (rVMAT2), resulting in reduced neuronal neuromelanin content and enhanced quantal size, and which increased the number of evoked quantal neurotransmitter release events from the terminals of cultured VM dopaminergic neurons Sulzer and Pothos, 2000) . To investigate whether enhanced vesicular uptake may decrease DA cyt and rescue neurons from L-DOPA-induced toxicity, we employed an adenoviral construct that resulted in overexpression of the recombinant VMAT2 in 80%-90% of both dopaminergic and nondopaminergic cells ( Figure S2 ).
VMAT2 overexpression significantly decreased DA cyt in L-DOPA-treated GFP + VM neurons (from 17.4 ± 1.7 mM, n = 74 neurons to 3.1 ± 0.8 mM, n = 28; Figure 4A ), but had no effects on GFP À neurons from the same culture (2.4 ± 0.8 mM, n = 33 versus 2.3 ± 1.9 mM, n = 7). GFP + neurons in cultures treated with a virus that did not contain rVMAT2 displayed the same DA cyt levels after L-DOPA treatment as control cells (data not shown). Consistent with the kinetics of L-DOPA metabolic consumption (Figure 1 ), rVMAT2 lowered DA cyt to the same extent in cells treated with 100 and 500 mM L-DOPA ( Figure 4A ). Moreover, infection with rVMAT2 effectively protected TH + neurons from the L-DOPA-mediated neurotoxicity ( Figure 4B ). It should be noted, however, that these data also suggest that somatic vesicles or other organelles that do not normally sequester substantial levels of DA can do so after transporter overexpression, as has been demonstrated for noncatecholaminergic AtT-20 cells and hippocampal neurons (Li et al., 2005) . a-Synuclein Knockout To investigate the role of a-syn in mediating DA cyt neurotoxicity, we generated a-syn-deficient mice that express eGFP in dopaminergic neurons (see Experimental Procedures). Whereas VM neurons from a-syn À/À and a-syn +/À mice were more resistant to L-DOPA-induced stress than neurons from their wild-type littermates ( Figure 4C ), IPE measurements indicated no difference in the DA cyt concentration between the three groups ( Figure 4D ). These data suggest that the pathogenic effect of a-syn is downstream of DA synthesis (see Discussion), and that the presence of both elevated DA cyt and a-syn is required for L-DOPA-induced neurotoxicity.
DA cyt in SN and VTA Neurons
To address the question of differential susceptibility of neurons from different brain regions, we prepared cultures that were enriched with cells from either SN or VTA, as previously published (Burke et al., 1998) . Immunolabeling for calbindin, a protein that is expressed at higher levels in VTA than in SN (Thompson et al., 2005) , showed that in mixed VM cultures $50% of TH + neurons were also calbindin + , whereas the proportion of TH + /calbindin + cells was $85% in VTA cultures and $25% in SN cultures (Figures 5A and 5B) . IPE measurements showed that L-DOPA-treated SN neurons displayed 2-to 3-fold higher DA cyt than VTA neurons ( Figure 5C ). This difference in DA cyt translated into a significantly higher susceptibility of SN neurons to L-DOPA-induced toxicity, whereas VTA neurons were almost completely protected ( Figure 5D ). The resistance of VTA neurons to L-DOPA challenge was also seen in mixed VM cultures, where after 4 days of 250 mM L-DOPA the percentage of TH + /calbindin + neurons increased from 52% to 88% (p < 0.05 by c 2 test).
Relationship between Cytoplasmic Ca 2+ and DA cyt
The regulation of intracellular Ca 2+ differs significantly between SN and VTA neurons (Gerfen et al., 1985; Surmeier, 2007; Thompson et al., 2005) . Thus, to search for the mechanism that governs the difference in DA cyt between the two neuronal Figure S3 ), consistent with previous reports (Rajadhyaksha et al., 2004; Striessnig et al., 2006) . The Ca v 1.2/Ca v 1.3 blockers nimodipine ( Figure 6A ) and nitrendipine (not shown), however, had no effect on DA cyt in L-DOPA exposed VTA neurons, but decreased DA cyt in SN neurons to the levels found in VTA neurons ( Figure S4 ). VM cultures treated with nimodipine were far more resistant to L-DOPA-induced neurodegeneration ( Figure 6B ). Pretreatment of SN neurons for 1 hr with the HCN channel antagonist ZD7288 (50 mM) or TTX (1 mM) had no significant effect on DA cyt reached after L-DOPA treatment (data not shown).
To determine which enzyme or transporter is responsible for Ca 2+ -induced upregulation of DA homeostasis, we first compared DA cyt in SN and VTA neurons treated with pargyline and reserpine. DA cyt was increased by the same percentile in both types of neurons ( Figure 6C ), suggesting that MAO and VMAT2 activities did not underlie the difference between DA cyt handling by SN and VTA neurons and were not the regulatory targets. Next, DA cyt in SN and VTA neuronal cultures was unaffected by the presence of the DAT blocker cocaine (data not shown). Finally, the uptake of L-DOPA in VM cultures pretreated with BAPTA-AM and benserazide was monitored by HPLC-EC and IPE in the amperometric detection mode, which in contrast to CV produces similar oxidative currents for DA and L-DOPA (Mosharov et al., 2003) . Measurements by both methods demonstrated that L-DOPA uptake was unaffected by Ca 2+ buffering ( Figures 6D and 6E) . Overall, our data suggest that MAO, VMAT, DAT, and the L-amino acid plasma transporter were not responsible for the difference in DA cyt observed between SN and VTA neurons. Thus, it appears that the activity of AADC may provide the Ca 2+ -sensitive metabolic step that leads to higher DA cyt levels in SN neurons. Neuron Dopamine, Calcium, a-Synuclein, and Neurotoxicity means to influence DA homeostasis indicate that neurotoxicity was mediated by the cytosolic pool of DA, whereas other potential sources of cellular stress, including extracellular DA and L-DOPA, played limited roles under our experimental conditions. To compare the data from different experiments, we examined the dependence of cell survival on the integral of cell exposure to elevated DA levels (DA cyt dose; Figure 7A ; Figure S5 ). The relationship was close to linear, with doses above 100-200 mM$hr causing significant neurotoxicity. This finding was consistent over a wide variety of interventions that altered DA cyt in different manners, including inhibition of L-DOPA conversion to DA, VMAT2 blockade or overexpression, and treatment with METH and cocaine. Cortical neurons were less resistant to L-DOPA challenge than midbrain DA neurons, although there are no reports of cell loss in the cortex of PD patients who received L-DOPA for many years. Conversely, VM neurons treated with the MAO inhibitor pargyline were significantly more resistant to DA cyt -mediated toxicity ( Figure 7A, asterisk) . One possible explanation for the lower than expected levels of cell death observed in the presence of MAO blockade is a contribution of DA catabolic products that arise via MAO activity, that is, H 2 O 2 and dihydroxyphenylacetaldehyde (DOPAL), as has been recently suggested (Burke et al., 2004; Eisenhofer et al., 2004) . Although additional studies are required to characterize other factors that modulate susceptibility of neurons to stress, our data support the exploration of central MAO inhibitors as treatments for PD either as monotherapy at early stages of the disease or in combination with L-DOPA in the advanced disease stages (Chen et al., 2007; Hauser et al., 2008) ; in both cases, MAO blockers would increase the availability of DA cyt for vesicular sequestration while preventing the buildup of toxic DA metabolites.
DISCUSSION

DA cyt Maintenance in Neuronal Somas and Synaptic Terminals
Perhaps surprisingly, reserpine and METH, drugs that disrupt vesicular DA sequestration, did not increase DA cyt , despite the depletion of vesicular DA stores evident from HPLC-EC measurements of the total intracellular DA (Figure 3 ; Larsen et al., 2002) . These results are, however, consistent with diffusion calculations, indicating that IPE measures only DA in the cell body (see Experimental Procedures), that is, the number of DA storage vesicles in the soma might be insufficient to detectably increase DA cyt following reserpine or METH. Although some DA secretory organelles reside in or close to neuronal cell bodies, as evident from somatodendritic vesicular DA release from midbrain neurons (Jaffe et al., 1998; Rice et al., 1997) , emptying one synaptic vesicle containing 10,000 DA molecules (Pothos et al., 1998) would increase DA cyt by only 0.01 mM (see Experimental Procedures), and 150-200 such vesicles would need to be emptied to produce a 10% increase over the 15-20 mM DA cyt observed in L-DOPA-treated cells. In comparison, adrenal chromaffin cells, which lack neurites and are filled with secretory vesicles that each contain $1,000,000 transmitter molecules (Wightman et al., 1991) , show increased cytosolic catechol concentrations following reserpine or METH (Mosharov et al., 2003) . Although IPE cannot measure DA cyt in axonal terminals, it is possible that a similarly large increase in DA cyt occurs in METH-treated neuronal terminals and, if so, this may explain the unusual pattern of METH-induced neurodegeneration in which neurites but not cell bodies are damaged in vitro (Cubells et al., 1994; Larsen et al., 2002) , in animal models in vivo (Ricaurte et al., 1982) , and in imaging studies of METH abusers after prolonged abstinence . Postmortem examination of chronic METH users reveals a more severe DA axonal loss in the caudate than in the putamen, presumably explaining the lack of parkinsonian symptoms in METH abusers (Moszczynska et al., 2004 buffering by BAPTA-AM. Conversely, significantly higher DA cyt was reached in SN than in VTA neurons, consistent with the pacemaking activity of dihydropyridine-sensitive Ca v 1.3 channels in SN but not VTA neurons. Notably, although dihydropyridines nimodipine and nitrendipine had no effect on DA cyt concentration in VTA neurons, they decreased DA cyt in SN neurons to the levels in the VTA, and provided neuroprotection from L-DOPA-induced cell death. The target of Ca
2+
-dependent upregulation of DA homeostasis appears to be the conversion of L-DOPA to DA by AADC. Although regulation of AADC activity via protein kinase A-and C-mediated phosphorylation has been reported (Duchemin et al., 2000; Young et al., 1998) , these mechanisms require further characterization, as Ca v 1.3 channels are also regulated by these second-messenger pathways (Baroudi et al., 2006; Rajadhyaksha and Kosofsky, 2005) . It should also be noted that Ca 2+ -dependent phosphorylation of TH (Dunkley et al., 2004 ) is likely to play a role in the absence of exogenously added L-DOPA.
A Multiple-Hit Hypothesis of SN Neurodegeneration in PD
Multiple genes have been identified to cause familial PD, but the disease may require multiple steps, such as an initial insult together with an insufficient stress response (Abou-Sleiman et al., 2006; Conway et al., 2001; LaVoie et al., 2005; MartinezVicente et al., 2008; Moore et al., 2005; Sang et al., 2007; Sulzer, 2007) , which may explain why known genetic and environmental factors do not straightforwardly account for idiopathic PD. The interaction between high DA cyt and a-syn may provide one of the multiple-hit mechanisms. Due to the presence of a-syn in Lewy bodies and the role of a-syn mutations or gene multiplication in some forms of familial PD, it is widely believed that this protein plays a central role in the degeneration of VM DA neurons. Consistent with previous reports that dopaminergic neurons in a-syn deficient mice show reduced susceptibility to neurotoxins (Alvarez-Fischer et al., 2008; Dauer et al., 2002) , we found that a-syn deletion makes VM neurons resistant to L-DOPA-induced toxicity. By contrast, neuronal DA cyt was unaffected by the absence of a-syn ( Figure 4D ), similar to cytosolic catecholamine levels in chromaffin cells from a-syn null animals (Mosharov et al., 2006) . These data are consistent with a toxic mechanism downstream of DA synthesis that may involve stabilization of toxic a-syn protofibrils by DA, inhibition of chaperonemediated autophagy by DA-modified a-syn, or a cumulative stress from various sources, which, in addition to DA cyt , Ca 2+ , and a-syn, may include mitochondrial and proteasomal dysfunction and inflammatory responses ( Figure 7B ) (Burke et al., 2008; Conway et al., 2001; Dauer and Przedborski, 2003; Gao et al., 2008; Martinez-Vicente et al., 2008; Ved et al., 2005) . Additionally, although normal expression levels of mouse wild-type a-syn do not seem to affect DA cyt concentration, a-syn mutation , and the buildup of DA cyt and its metabolites. Nonexclusive toxic steps may result from (1) mechanisms that require direct interaction between DA or its metabolites with a-syn, such as DA-modified stabilization of a-syn protofibrils or inhibition of chaperone-mediated autophagy, or (2) cumulative damage from multiple independent sources. Decreasing the levels of any of the three players provides neuroprotection.
Neuron
Dopamine, Calcium, a-Synuclein, and Neurotoxicity or overexpression may lead to elevated DA cyt (Lotharius et al., 2002; Mosharov et al., 2006 ) that would further exacerbate neurotoxicity.
It is striking that L-DOPA doses that produced neurotoxicity in this study also induce the synthesis of neuromelanin , an autophagosome containing oxidized dopamine products (Sulzer et al., 2008) . Moreover, VMAT2 overexpression, which as we show here decreased DA cyt and abolished L-DOPAinduced neuronal death, has also been demonstrated to inhibit neuromelanin synthesis . Together, these data support the idea that neuromelanin synthesis is a stress response and that the presence of neuromelanin in human SN and its accumulation over time are indicative of an ongoing DA cyt damage even in normal non-PD human brain. Conversely, dopaminergic neurons in the VTA, which are spared in PD, produce minimal neuromelanin over a lifetime (Hirsch et al., 1988; Liang et al., 2004; Zecca et al., 2001) .
Whereas DA neurons are comparatively resistant to DA cyt toxicity, it remains unclear whether neurotoxic DA cyt levels are reached in humans, particularly during treatment of PD patients with L-DOPA. Although L-DOPA therapy is linked to increased levels of the products of peroxynitrite-mediated oxidative stress in cerebrospinal fluid (CSF) (Isobe et al., 2006) and a more rapid decline in striatal dopamine transporter over the course of L-DOPA therapy, there is no increase in the rate of symptomatic progression in PD patients with L-DOPA (Fahn, 2005) . Moreover, whereas recent reports demonstrate L-DOPA-induced neurotoxicity in rodents (Chen et al., 2008; Jeon et al., 2007) , other in vivo studies found L-DOPA to be benign or even neuroprotective (reviewed by Olanow et al., 2004) . Important factors may include the ability of L-DOPA-induced mild oxidative stress to activate glutathione synthesis (Han et al., 1996; Mena et al., 1997) and induce macroautophagy (Sulzer et al., 2008) , and a likely protective action of L-DOPA therapy on the striatopallidal pathway (Day et al., 2006) . Normal L-DOPA concentration in the CSF is only $5 nM (Tohgi et al., 1997) and increases to $300 nM in L-DOPA-treated patients (Tohgi et al., 1995) , which is likely within a range that cellular stress response pathways can handle. It should be emphasized that the meaning of our findings is not that L-DOPA is neurotoxic to humans, as it is artificially used as a tool to enhance DA: genuine PD does not result from L-DOPA exposure, but may result following chronically elevated DA cyt and the presence of other genetic and environmental hits.
The newly identified relationship between high Ca 2+ and DA cyt may underlie the selective vulnerability of dopaminergic neurons in SN and locus coeruleus, a group of noradrenergic neurons that also rely on Ca 2+ channel pacemaking (Williams et al., 1984) . If so, various strategies could be employed to prevent neuronal death in PD, including an inhibition of Ca v 1.3 channel activity (Surmeier, 2007) or blocking the deleterious effects of DA-protein interactions (Martinez-Vicente et al., 2008) . By contrast, symptomatic treatment of PD relies on therapies that enhance synaptic vesicle sequestration of DA, thereby reconstituting the dopaminergic tone in the striatum. As discussed above, our data may indicate advantages to using central MAO inhibitors as PD drugs. Likewise, as we show here, VMAT2 overexpression enhances exocytotic DA release while decreasing DA cyt . Because VMAT2 overexpression not only promotes DA neurotransmission in a manner similar to L-DOPA but also confers neuroprotection, controlled VMAT2 overexpression may provide a therapeutic intervention for PD, either alone or in combination with L-DOPA or MAO blockers.
EXPERIMENTAL PROCEDURES Mouse Strains
For neurotoxicity and IPE experiments, neurons from C57/Bl6 mice or from transgenic mice that express green fluorescent protein (TH-GFP +/À ) under the control of the rat tyrosine hydroxylase (TH) promoter (Sawamoto et al., 2001 ) were used. a-synuclein null mice that express eGFP under the control of TH promoter were generated in two steps. TH-GFP +/À mice were crossed with a-syn À/À mice (strain B6;129X1-Snca tm1Rosl /J from Jackson Labs; originally from Abeliovich et al., 2000) . Next, the resulting TH-GFP 
Primary Neuronal Cultures
Ventral midbrain (VM), cortical, or striatal neurons from postnatal day 0-2 mice or rats were dissected, dissociated, and plated on a monolayer of cortical astrocytes at the plating density of $100,000 cells/cm 2 , as previously described (Burke et al., 1998; Rayport et al., 1992) . Mouse neurons were cultured on glass poly-D-lysine-coated coverslips attached to $0.8 cm 2 wells cut into 50 mm dishes. Rat neurons were cultured on 35 mm tissue culture dishes ($9.6 cm 2 ).
We previously reported (Mena et al., 1997) that lower levels of L-DOPA provided a short-lasting enhancement of dopaminergic neuron survival due to neuroprotective antioxidant responses to L-DOPA-induced oxidative stress. We have since demonstrated that glial-derived neurotrophic factor (GDNF) is selectively neuroprotective for postnatally derived dopaminergic neurons, providing markedly enhanced survival (Burke et al., 1998) , and now routinely include this component in the culture medium. As shown in the present study, L-DOPA is not neuroprotective in the presence of GDNF (Figure 2A ), presumably because the neuroprotective response has been occluded, allowing the toxic response to be revealed.
Experiments were conducted 6-10 days postplating; all treatments were performed at 37 C. Pseudo-3D images of cultured TH-GFP neurons (Figure S1) were obtained with a two-photon microscope (Zeiss Axioskop2 FS MOT upright microscope, LSM 510 Coherent two-photon setup; Carl Zeiss MicroImaging, Thornwood, NY, USA), using 850 nm excitation and 525 nm emission wavelengths. Z sections were taken at 1 mm increments. Other images were acquired on a conventional fluorescence microscopy setup (Zeiss Axiovert 100 microscope) equipped with a Zeiss AxioCam MRm camera and FITC and rhodamine filter sets (Chroma, Rockingham, VT, USA).
Adenoviral Vector Construction and Transfection of Neurons with rVMAT2
A hemagglutinin (HA) -tagged VMAT2 cDNA was first subcloned into the shuttle vector pTet-EF, then coinfected with donor virus DNA (45) into HEK293 cells expressing Cre recombinase, and the resultant VMAT2-HAharboring adenovirus was purified and stored as previously described at $8000 pfu/ml (Krantz et al., 1997) . Primary rat VM cultures were incubated with 1 ml of rVMAT2 diluted in 100 ml of media for 5 hr and then 2 ml of media was added to each dish; 45 alone was used as a negative (empty virus) control. Transfection efficiency was 80%-90% for both dopaminergic and GABAergic neuronal types ( Figure S2 ).
Immunocytochemistry and Western Blots
Immunostaining of 4% paraformaldehyde-fixed cultures was performed using mouse or rabbit anti-TH (1:1000; Chemicon, Temecula, CA, USA), rabbit . Western immunoanalysis of VMAT2 protein was performed as described (Krantz et al., 1997) with VMAT2 antibody (1:500; Chemicon), horseradish peroxidase-conjugated secondary antibody, and visualization by enhanced chemiluminescence (Pierce Biotech, Rockford, IL, USA).
Neurotoxicity Cells were preincubated with rVMAT2 for 1 day and with various DA metabolism inhibitors for 1 hr before the application of L-DOPA, unless stated otherwise. Following 1-7 days of incubation, neuronal cultures were fixed and stained for TH (VM neurons) or MAP2 (cortical and striatal neurons). The total numbers of immunoreactive neurons were then tallied and analyzed as previously described . Alternatively, neuronal density was assessed by counting the number of immunoreactive cells in 24 fields of view at 2003 magnification (Plan-Neofluar 203 objective; $0.8 mm 2 viewing field) and taking the average as a representative for each dish. Although the two methods yielded similar results, the second approach was more robust, producing lower deviation within experimental groups. The counts were performed by an observer blind to the experimental treatments.
High-Performance Liquid Chromatography with Electrochemical Detection
Whole-cell DA, dihydroxyphenylacetic acid (DOPAC), and L-DOPA levels were determined by HPLC-EC as previously described (Feigin et al., 2001; Larsen et al., 2002) . DA, DOPAC, and L-DOPA amounts were calculated from areas under HPLC peaks using calibration curves and normalized to protein concentrations in each sample.
Intracellular Patch Electrochemistry
Measurements of cytosolic DA (DA cyt ) concentrations in neurons were based on protocols for PC12 cells and chromaffin cells (Mosharov et al., 2003 (Mosharov et al., , 2006 . A polyethylene-coated 5 mm carbon fiber electrode (CFE) was placed inside a glass patch pipette and used in cyclic voltammetric (CV) mode of detection where voltage ramps from À450 mV holding potential to +800 mV and back to À450 mV over 10 ms (scan rate of 250 mV/ms) were applied at 100 ms intervals. After achieving a seal between the cell and the patch pipette, the plasma membrane was ruptured by suction and substances diffusing from the cytosol into the pipette were observed as a slow wave of oxidation current. As no difference was found between IPE signals using intracellular and extracellular ionic compositions as the patch pipette saline (Mosharov et al., 2003) , the same saline was employed as the bath and the pipette solutions in the present study. The saline contained (in mM): 118 NaCl, 2.5 KCl, 2 MgCl 2 , 2 CaCl 2 , 1 NaH 2 PO 4 , 10 glucose, 25 HEPES-NaOH (pH 7.4); the same concentrations of all drugs, including L-DOPA, were present in the bath and in the patch pipette. After background current subtraction, the concentration of DA at the pipette tip was calculated as previously described (Mosharov et al., 2003) . IPE sensitivity, estimated as the current 3-fold higher than the root mean square of the noise on the subtraction voltammogram, was $100 nM DA; the calibration curves were log-linear for up to at least 1 mM DA concentration (Mosharov et al., 2003) . The initial concentration of DA cyt was calculated using neuronal cell-body volume, and the volume of the pipette tip was estimated from photographs taken before each recording ( Figure S1 ). To investigate whether the electrode sensitivity for DA was affected by the presence of compounds present in the recording media, we performed a series of calibration measurements of 5 mM DA with and without the drugs (Table S1 ). Based on these data, NSD-1015 cannot be used for IPE experiments because it abolished the oxidation signal of DA.
Although CV voltammograms cannot differentiate between DA, L-DOPA, and the product of DA catabolism, DOPAC, there are several reasons to suspect that DA represented the majority of the cytosolic oxidation signal estimated by IPE. First, the sensitivity of CV is 15-to 20-fold higher for DA molecules than for other catechols (Mosharov et al., 2003) . Second, there were identical concentrations of L-DOPA present in the patch pipette and extracellular saline during the recordings; thus, any change in the oxidation signal after achieving the whole-cell configuration could not be due to the influx of L-DOPA into the patch pipette per se. Third, L-DOPA is rapidly converted to DA once in the cytosol, and enhanced DA can be measured in these cultures within 90 s (Pothos et al., 1998) , whereas, as shown in Results, inhibition of AADC almost completely abolished the oxidation signal from L-DOPA-treated cells. Finally, neither L-DOPA nor DOPAC are VMAT2 substrates, arguing against a possibility that the observed decrease in the cytosolic signal in neurons overexpressing VMAT2 was due to nonspecific catechol uptake into the vesicles.
To estimate the contribution of neurotransmitter from neurites to the CV oxidation signal, we calculated the time required for DA to diffuse into the cell body and then into the patch pipette. The average neuronal soma diameter and the distance from the cell to the CFE measured from photographs acquired before the recordings were 17.3 ± 3.9 mm and 16.6 ± 3.9 mm, respectively. Diffusion time (t) was calculated as t = x 2 /2D, where x is the distance and D is the DA diffusion coefficient, 2.7*10 À6 cm 2 /s (Nicholson, 1999) . It follows that DA from the middle of the cell body (x = 25.3 mm) would reach the CFE in 1.2 s, which was close to the average time to oxidation peak maximum experimentally observed in IPE recordings (1.4 ± 0.8 s, mean ± SEM, n = 34 neurons; Figure S1 ). In contrast, it would take approximately ten times longer for DA to diffuse from a varicosity positioned three cell-body diameters away (x = 77.1 m); this delay would be longer still if the shape and diffusional barriers within the neurite were taken into account. We conclude that the majority of DA measured by IPE represents neurotransmitter that resided within the neuronal soma.
Possible Influence of Vesicular DA Cargo on the DA cyt Measurements If one synaptic vesicle releases all its content inside the neuronal soma, the change in the DA cyt concentration will equal Q N /N A /V cell , where Q N is vesicular quantal size ($10,000 molecules in L-DOPA-treated neuronal synaptic vesicles; Pothos et al., 1998) , N A is Avogadro's Constant (6.023*10 23 molecules/mol), and V cell is the cell-soma volume ($1.77 pl for a cell with a diameter of 15 mm). It follows that emptying one vesicle would increase DA cyt by 10 nM, although this value might be underestimated because the effective cytosolic volume is smaller due to the presence of other organelles. In a similar scenario inside a synaptic terminal ($1 mm in diameter), DA cyt will be increased by >30 mM.
Statistical Analyses
Statistical analysis was performed in Prism 4 (GraphPad Software, La Jolla, CA, USA), using one-way analysis of variance (ANOVA) followed by Tukey's post hoc test for comparisons across multiple groups or two-way ANOVA with Bonferroni post test for the paired data.
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